Xtandi
enzalutamide
- Strength
- 40 mg/1
- Form
- Capsule
- Class
- Androgen Receptor Inhibitor
Astellas Pharma US, Inc.
Xtandi
enzalutamide
Listed by Astellas Pharma US, Inc.
- Strength
- 40 mg/1
- Form
- Capsule
- Route
- Oral
- Class
- Androgen Receptor Inhibitor
What it contains
- Enzalutamide 40 mg/1
FDA record
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Androgen Receptor Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 0469-1125 |
| FDA application | NDA203415 |
| RxNorm concept | 1307303 |
| Package sizes listed | 1 |
| Marketed since | August 2012 |
Other products containing Enzalutamide
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Xtandi
enzalutamide
- Strength
- 40 mg/1
- Form
- Tablet
- Class
- Androgen Receptor Inhibitor
Astellas Pharma US, Inc.
Xtandi
enzalutamide
- Strength
- 40 mg/1
- Form
- Tablet
- Class
- Androgen Receptor Inhibitor
Astellas Pharma US, Inc.
Xtandi
enzalutamide
- Strength
- 80 mg/1
- Form
- Tablet
- Class
- Androgen Receptor Inhibitor
Astellas Pharma US, Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.